| Literature DB >> 31145054 |
Terumasa Ikeda1,2,3,4,5, Amy M Molan5,1,2,4, Matthew C Jarvis2,4,5,1, Michael A Carpenter2,4,5,1,3, Daniel J Salamango4,5,1,2, William L Brown5,2,1,4, Reuben S Harris2,4,5,1,3.
Abstract
HIV-1 replication in CD4-positive T lymphocytes requires counteraction of multiple different innate antiviral mechanisms. Macrophage cells are also thought to provide a reservoir for HIV-1 replication but less is known in this cell type about virus restriction and counteraction mechanisms. Many studies have combined to demonstrate roles for APOBEC3D, APOBEC3F, APOBEC3G and APOBEC3H in HIV-1 restriction and mutation in CD4-positive T lymphocytes, whereas the APOBEC enzymes involved in HIV-1 restriction in macrophages have yet to be delineated fully. We show that multiple APOBEC3 genes including APOBEC3G are expressed in myeloid cell lines such as THP-1. Vif-deficient HIV-1 produced from THP-1 is less infectious than Vif-proficient virus, and proviral DNA resulting from such Vif-deficient infections shows strong G to A mutation biases in the dinucleotide motif preferred by APOBEC3G. Moreover, Vif mutant viruses with selective sensitivity to APOBEC3G show Vif null-like infectivity levels and similarly strong APOBEC3G-biased mutation spectra. Importantly, APOBEC3G-null THP-1 cells yield Vif-deficient particles with significantly improved infectivities and proviral DNA with background levels of G to A hypermutation. These studies combine to indicate that APOBEC3G is the main HIV-1 restricting APOBEC3 family member in THP-1 cells.Entities:
Keywords: APOBEC3G; G to A hypermutation; HIV-1 restriction; Vif; myeloid cell line THP-1
Mesh:
Substances:
Year: 2019 PMID: 31145054 PMCID: PMC7176283 DOI: 10.1099/jgv.0.001276
Source DB: PubMed Journal: J Gen Virol ISSN: 0022-1317 Impact factor: 3.891